Office of the Australian Information Commissioner

Most companies targeted for ransomware payments cough up. For law firms, a decision to pay is mired in ethical and regulatory challenges.

The Albanese government's world-first plan to ban kids from social media is a risky political move that could also become a litigious nightmare.

Australia’s privacy chief says AI privacy laws are “clear cut". Lawyers speaking with Capital Brief say businesses are still confused.

Allowing individuals to sue over privacy breaches risks court challenges and appeals that could undermine the statutory tort before it takes effect, the tech industry peak body has warned.

Businesses using AI may face complex privacy requirements, but there is no "grey area" in existing laws, Kind told Capital Brief.

Amid fierce competition for top lawyers, the appetite for overseas moves has picked up, giving firms with an international presence an edge in hiring and retaining talent.

Australian regulators say they must find new ways to investigate and enforce against corporate wrongdoing and consumer harms as generative AI use increases.

With new legislation to overhaul Australia's Privacy Act now due in August, Privacy Commissioner Carly Kind outlines the regulator's plans to become a tougher enforcer and the 'multiple ways to skin the cat of AI governance.'

The Productivity Commission is urging policymakers to balance the need to manage consent requirements of collecting data while pursuing the potential productivity and economic gains AI has to offer.

Latitude Financial's 2023 data breach saw millions of customer details stolen. New Zealand's privacy regulator says a "right to erasure" could have prevented some of that.

Australia's top privacy regulator is urging lawmakers to act now to create safeguards for consumers and businesses against the rise of artificial intelligence

Australian Clinical Labs appeared in court for the first time in its privacy law legal battle linked to its handling of a 2022 data breach.

The OAIC case against Australian Clinical Labs shows the regulator is prepared to back up talk with action.

The tendency for companies to hold on to CVs leaves them vulnerable to the dual threat of privacy-law enforcement and cyberattacks.